Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae

Infection and Immunity

Volumn 70, Issue 2, 2002, Pages 749-761

  Khan, Abdul Q ^a   Shen, Yi ^a   Wu, Zheng Qi ^a   Wynn, Thomas A ^a   Snapper, Clifford M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PNEUMOCOCCUS SURFACE PROTEIN A; PROTEIN PSPA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CELL WALL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HOST RESISTANCE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CYTOKINES; FEMALE; GENE EXPRESSION; HEAT-SHOCK PROTEINS; IMMUNIZATION; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-6; LIPOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLCHOLINE; PHOTOSYSTEM I PROTEIN COMPLEX; STREPTOCOCCUS PNEUMONIAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036156077     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.2.749-761.2002     Document Type: Article

References (84)

1. Strategies for anticytokine monoclonal antibody development: Immunoassay of IL-10 and IL-5 in clinical samples
2. Toll-like receptors: Lessons from knockout mice
3. Streptococcus pneumoniae: Virulence factors, pathogenesis, and vaccines
4. NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion
5. Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a deoxyribonucleic acid fraction isolated from pneumococcus type III
6. Dendritic cells and the control of immunity
7. Immunobiology of dendritic cells
8. Inhibition Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12
9. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins
10. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens
11. Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae
12. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
13. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacterfelis infection
14. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation. In vitro and therapeutic anti-tumor immune responses in vivo
15. Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells
16. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies
17. Clonal nature of the immune response to phosphorycholine. I. Specificity, class, and idiotype of phosphorycholine-binding receptors on lymphoid cells
18. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma
19. Dendritic cells pulsed with intact Streptococcus pneumoniae elicit both protein- and polysaccharide-specific immunoglobulin isotype responses in vivo through distinct mechanisms
20. Interleukin-4 production in response to infection with intracellular bacteria
21. Uncoupling of inflammatory chemokine receptors by IL-10: Generation of functional decoys
22. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression
23. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance
24. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes
25. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex
26. A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae
27. Antibodies to cachectin/tumor necrosis factor reduce interleukin1β and interleukin 6 appearance during lethal bacteremia
28. Potential antiinflammatory effects of interleukin 4: Suppression of human monocyte tumor necrosis factor α, interleukin 1, and prostaglandin E2
29. Gamma interferon augments macrophage activation by lipopolysaccharide by two distinct mechanisms, at the signal transduction level and via an autocrine mechanism involving tumor necrosis factor alpha and interleukin-1
30. Cytokine induction by bacteria: Beyond lipopolysaccharide
31. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes
32. In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease
33. Productions of opsonins that facilitate phagocytosis of Streptococcus pneumoniae by human alveolar macrophages or neutrophils after vaccination with pneumococcal polysaccharide
34. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria
35. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli
36. T cellderived B cell differentiation factor(s). Effect on the isotype switch of murine B cells
37. Pathogenesis of pneumococcal pneumonia
38. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway
39. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha)
40. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
41. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
42. Impaired immune and acute-phase responses in interleukin-6-deficient mice
43. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component
44. Interleukin-10 down-regulates MHC class II ab peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling
45. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage
46. Lethal tuberculosis in interleukin-6 deficient mice
47. Gene expression and production of tumor necrosis factor alpha, interleukin-1β (IL-1β), IL-8, macrophage inflammatory protein lα (MIP-1α), MIP1β, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B meningococcal outer membrane vesicles
48. Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NF-kappaB
49. Regulation of transforming growth factor-β production by interleukin-12
50. TNFalpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice
51. Innate immunity: The virtues of a nonclonal system of recognition
52. Enhancement of humoral immunity by interleukin-12
53. T cell-independent antigens type 2
54. Interleukin-10
55. IL-4 promotes the migration of circulating B cells to the spleen and increases splenic B cell survival
56. Induction of interleukin-4 (IL-4) by Legionella pneumophila infection in BALB/c mice and regulation of tumor necrosis factor alpha, IL-6, and IL-1β
57. Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae
58. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases
59. Interleukin 4/B cell stimulatory factor 1: One lymphokine, many functions
60. Expression, purification and preliminary X-ray crystallographic analysis of PsaA, a putative metal-transporter protein of Streptococcus pneumoniae
61. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores
62. A soluble factor produced by lamina propria mononuclear cells is required for TNF-α enhancement of IFN-γ production by T cells
63. Phagocytic antigen processing and effects of microbial products on antigen processing and T-cell responses
64. The role of interleukin-6 in mucosal IgA antibody responses in vivo
65. The immunoglobulin allotype contributed by peritoneal cavity B cells dominates in SCID mice reconstituted with allotype-disparate mixtures of splenic and peritoneal cavity B cells
66. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans
67. The role of chemokine receptors in primary, effector, and memory immune responses
68. Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon
69. Heat-killed Streptococcus suis capsular type 2 strains stimulate tumor necrosis factor alpha and interleukin-6 production by murine macrophages
70. IL-10 selectively regulates murine Ig isotype switching
71. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production
72. Induction of IgG3 secretion by interferon γ: A model for T cell-independent class switching in response to T cell-independent type 2 antigens
73. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching
74. High-level IL-12 production by human dendritic cells requires two signals
75. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans
76. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
77. Interleukin 12 and tumor necrosis factor a are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listerosis, and interleukin 10 is a physiologic antagonist
78. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production
79. Peptidoglycan and lipoteichoic acid from staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model
80. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens
81. Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2
82. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions
83. B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae